Who owns CNS Pharmaceuticals Inc?
- Ticker: CNSP
- CUSIP Number: 18978h508
Tip: Access positions for across all investors
Analyze quarterly positions in CNS Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of CNS Pharmaceuticals stock
Who bought or sold CNS Pharmaceuticals Inc this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Stonepine Capital Management | 49k | $256k | 100% | Dec 2025 |
|
| Ikarian Capital | 46k | $241k | 100% | Dec 2025 |
|
| DRW Holdings | 15k | $81k | 10% | Dec 2025 |
|
| Boothbay Fund Management | 14k | $71k | 100% | Dec 2025 |
|
| UBS Group | 611.00 | $3.2k | -94% | Dec 2025 |
|
| Barrett & Company | 8.00 | $42.000000 | 0% | Dec 2025 |
|
| MAI Wealth Advisors | 3.00 | $15.999900 | 0% | Dec 2025 |
|
| Danske Bank A/s | 1.00 | $5.000000 | 0% | Dec 2025 |
|